| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pazopanib iv | 1.62 | 0.5 | 2574 | 44 | 12 |
| pazopanib | 1.63 | 0.3 | 8617 | 72 | 9 |
| iv | 1.86 | 0.4 | 8151 | 33 | 2 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pazopanib eviq | 1.21 | 0.5 | 1286 | 80 |
| pazopanib vidal | 0.48 | 0.6 | 4050 | 68 |
| pazopanib votrient | 1.49 | 0.9 | 4542 | 57 |
| pazopanib vegf | 0.29 | 0.7 | 2070 | 14 |
| pazopanib vs sunitinib | 0.69 | 0.7 | 1804 | 32 |
| pazopanib vhl | 1.43 | 1 | 6598 | 83 |
| pazopanib ic50 | 0.28 | 1 | 6812 | 39 |
| pazopanib vs cabozantinib | 0.25 | 0.7 | 9795 | 88 |
| pazopanib immunotherapy | 1.64 | 1 | 9190 | 87 |
| pazopanib impurities | 0.92 | 0.8 | 3738 | 75 |
| pazopanib immunotherapy soft tissue sarcoma | 1.1 | 0.2 | 3799 | 75 |
| pazopanib ovarian cancer | 1.28 | 0.9 | 9715 | 86 |
| pazopanib ovarialkarzinom | 1.17 | 0.9 | 4156 | 20 |
| pazopanib indication | 0.05 | 0.8 | 7380 | 27 |
